tetano
Editor, Senior Moderator
J Am Acad Dermatol. 2020 Apr 9. pii: S0190-9622(20)30522-3. doi: 10.1016/j.jaad.2020.03.099. [Epub ahead of print]
The use of Janus kinase inhibitors in the time of SARS-CoV-2.
Peterson D[SUP]1[/SUP], Damsky W[SUP]1[/SUP], King B[SUP]2[/SUP].
Author information
KEYWORDS:
COVD-19; Janus kinase inhibitors; SARS-CoV-2; autoimmune disease; coronavirus; general dermatology; immunomodulators; immunosuppressants; medical dermatology
PMID:32278797DOI:10.1016/j.jaad.2020.03.099
The use of Janus kinase inhibitors in the time of SARS-CoV-2.
Peterson D[SUP]1[/SUP], Damsky W[SUP]1[/SUP], King B[SUP]2[/SUP].
Author information
KEYWORDS:
COVD-19; Janus kinase inhibitors; SARS-CoV-2; autoimmune disease; coronavirus; general dermatology; immunomodulators; immunosuppressants; medical dermatology
PMID:32278797DOI:10.1016/j.jaad.2020.03.099